SLS
SLS
NASDAQ · Biotechnology

Sellas Life Sciences Group I

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.05
+0.29 (+3.74%)
As of Jun 21, 10:20 PM ET ·
SLS News2 articles
SELLAS Shares Surge as AML Trial Nears Final Data Trigger
SELLAS Life Sciences shares climbed 4.1% to $7.59 on Tuesday after the CEO disclosed the REGAL trial is nearing the 80-event threshold for final analysis.
Markets
SELLAS Stock Surges as REGAL Trial Nears Final Analysis
SELLAS Life Sciences shares rose after hours as its REGAL leukemia trial recorded 78 of 80 events needed for final analysis. The company reported a Q1 net loss of $8.4 million but has $107.1 million in cash.
Analysis